2017

Our medical news may contain material that is considered promotional and is therefore intended for medical journalists and health care professionals only. By clicking through to see medical news, you are confirming that you are a medical journalist or healthcare professional.

Q4

Press releases
05.12.2017 Participation in PSCI (Pharmaceutical Supply Chain Initiative)
Press releases
Shionogi Sponsor new exhibit at the Science Museum, London

Q1

Press releases
Symproic (naldemedine) approved for the treatment of Opioid-Induced Constipation in Japan
Press releases
EMA accepts MAA submission of Shionogi's naldemedine for the treatment of Opioid Induced Constipation
Press releases
FDA approves Symproic (naldemedine) once-daily tablets C-II for the treatment of Opioid-Induced Constipation in Adults with chronic non-cancer pain

Back  number